Cardiac Output Monitoring Devices Market Size & Share, by Product (Consumables & Accessories, Devices); Type (Invasive, Non-Invasive); Technology (Pulmonary Artery Catheter, Lithium Dilution Technique); End-user (Hospitals, Ambulatory Surgical Centers) - Global Supply & Demand Analysis, Growth Forecasts, Statistics Report 2023-2033

Request Free Sample Copy

Report ID: 4217
Published Date: Feb 14, 2023
Report Format: PDF, PPT

Buy Now

Companies Dominating the Cardiac Output Monitoring Devices Landscape

ICU Medical, Inc.
- Company Overview
- Business Strategy
- Key Product Offerings
- Financial Performance
- Key Performance Indicators
- Risk Analysis
- Recent Development
- Regional Presence
- SWOT Analysis

Schwarzer Cardiotek GmbH
Edwards Lifesciences Corporation
Baxter International, Inc.
Deltex Medical plc
CNSystems Medizintechnik GmbH
Abiomed, Inc.
Boston Scientific Corporation (BSC)
BioTelemetry, Inc.
Masimo Corporation

Browse Key Market Insights with Data Illustration:

Cardiac Output Monitoring Devices Market Size, Growth Trends 2033

In the News

ICU Medical Inc. acquired Smiths Medical from Smiths Group Plc. In addition to syringes and ambulatory infusion devices, Smith Medical also produces vascular access products and vital care products.
Schwarzer Cardiotek GmbH received 510(k) clearance from the US Food and Drug Administration for version 2.2 of its EP-TRACER electronic physiological measurement system, designed to provide a high-quality display of intracardiac ECG signals.

Frequently Asked Questions (FAQ)

Worldwide increasing elderly population, rising prevalence of chronic obstructive pulmonary disease (COPD), and an upsurge in surgical procedures are the major factors driving the market growth.

The market is anticipated to attain a CAGR of ~4% over the forecast period, i.e., 2023-2033.

Restricted application of cardiac output monitoring devices, preference for medicines over surgery, and limited insurance coverage options are estimated to be the growth hindering factors for the market expansion.

The market in the North American region is projected to hold the largest market share by the end of 2033 and provide more business opportunities in the future.

The major players in the market are ICU Medical, Inc., Baxter International, Inc., Deltex Medical plc, Boston Scientific Corporation (BSC), BioTelemetry, Inc., and others.

The company profiles are selected based on the revenues generated from the product segment, geographical presence of the company which determine the revenue generating capacity as well as the new products being launched into the market by the company.

The market is segmented by product, type, technology, end user, and by region

The invasive segment is anticipated to garner t he largest market size by the end of 2033 and display significant growth opportunities.

Companies Dominating the Cardiac Output Monitoring Devices Landscape

Browse Key Market Insights with Data Illustration:

In the News

Frequently Asked Questions (FAQ)

What are the major factors driving the growth of the cardiac output monitoring devices market?

What would be the CAGR of cardiac output monitoring devices market over the forecast period?

What are the challenges affecting the cardiac output monitoring devices market growth?

Which region will provide more business opportunities for growth of cardiac output monitoring devices market in future?

Who are the major players dominating the cardiac output monitoring devices market?

How are the company profiles selected?

What are the segments in the cardiac output monitoring devices market?

Which segment captures the largest market size in type segment in the cardiac output monitoring devices market?